These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26643412)

  • 1. Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mononuclear cells.
    Uchida D; Shiraha H; Kato H; Sawahara H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1154-9. PubMed ID: 26643412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
    Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
    Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
    Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
    Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.
    Gu YM; Ma YH; Zhao WG; Chen J
    World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
    Guo Q; Qin W
    J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.
    Suzawa K; Shien K; Peng H; Sakaguchi M; Watanabe M; Hashida S; Maki Y; Yamamoto H; Tomida S; Soh J; Asano H; Tsukuda K; Nasu Y; Kumon H; Miyoshi S; Toyooka S
    Anticancer Res; 2017 Jan; 37(1):301-307. PubMed ID: 28011506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
    Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
    PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
    Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Dickkopf-3 overexpression in esophageal adenocarcinoma.
    Wang Z; Lin L; Thomas DG; Nadal E; Chang AC; Beer DG; Lin J
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):377-385.e2. PubMed ID: 26093488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of Tumor Infiltrating γδ T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppressor, 4-Methylumbelliferone.
    Suto A; Kudo D; Yoshida E; Nagase H; Suto S; Mimura J; Itoh K; Hakamada K
    Pancreas; 2019 Feb; 48(2):292-298. PubMed ID: 30589828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
    Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
    Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
    Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
    Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
    Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
    Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.